HIGHLIGHTS
- who: Ductal Adenocarcinoma Progression and colleagues from the Institute of Physiology II, University of Münster, Münster, Germany, Department of Experimental and Clinical Medicine, Section have published the paper: Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy, in the Journal: (JOURNAL)
- what: The great majority of the studies using ion_channel blockers or activators are aimed to target cancer cells, rather than immune or stroma cells. The authors collected the current knowledge of ion_channels in PDAC with a particular focus on immune and stromal cells and discussed the feasibility of therapeutic ion_channel targeting.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.